4-Ethyl-9-(4-hydroxyphenyl)-1-oxa-4,9-diazaspiro[5,5]undecan-3-one → 1-(3-Bromopropyl)piperidine Hydrobromide
Reaction equation
C(N1CC2(CCN(C3C=CC(O)=CC=3)CC2)OCC1=O)C.Br.[Br:23][CH2:24][CH2:25][CH2:26][N:27]1[CH2:32][CH2:31][CH2:30][C@H:29](C)[CH2:28]1>>[BrH:23].[Br:23][CH2:24][CH2:25][CH2:26][N:27]1[CH2:32][CH2:31][CH2:30][CH2:29][CH2:28]1Participants
3
Procedure
The entitled compound was obtained as a pale yellow solid, according to the same method as in Example 5-(c) or according to a method similar to it but using 4-ethyl-9-(4-hydroxyphenyl)-1-oxa-4,9-diazaspiro[5,5]undecan-3-one obtained in Example 5-3-(b), and (3S)-1-(3-bromopropyl)-3-methylpiperidine hydrobromide obtained in Reference Example 4 in place of 1-(3-bromopropyl)piperidine hydrobromide.
Workup
- customThe entitled compound was obtained as a pale yellow solid
Sources & evidence
- ORD record
- ord-271f5b1d857040b19f3a0e667364b4cc
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08138206B2
Reaction notes
Loading…